June 2010

|
Volume 10 Issue 6

Editorial Staff

Clinical Editor
Bradley Knight, MD
Executive Editor
Laurie Gustafson
Managing Editor
Jodie Elrod
Production Manager
Alexa Flinn

Editorial Correspondence

Jodie Elrod, Managing Editor, EP Lab Digest
HMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (800) 371-0791

Fax: (866) 488-8273
Email: jelrod@hmpglobal.com
   David H. Fater, CEO of Vicor Technologies, Inc., announced the initial results of a study designed to analyze data from the Merte Subita en Insufficiencia Cardiaca (MUSIC) Trial using itsPD2i®algorithm and software. VicorTechnologiesis a biotechno…
In order to be successful, organizations need to make a strong commitment toward physician recruitment. In this feature article, author Jessica Barrick provides insight into how your organization can be perceived by potential candidates.    With cur…
   Cameron Health, Inc. announced the publication of study results online in the New England Journal of Medicine (NEJM) highlighting the development and potential benefits of the company’s S-ICD® System, the first minimally invasive, subcutaneous imp…
   St. Jude Medical, Inc. and iRhythm Technologies, Inc., a privately-held company, announced they have entered into partnership with a focus on iRhythm’s ZioTM Patch. iRhythm also announced closure of a $10 million private equity round of financing,…
   AtriCure, Inc. announced that it has received conditional approval from the FDA to evaluate the safety and efficacy of a dual epicardial/endocardial procedure (DEEP), or hybrid procedure, to treat patients with persistent and long-standing persist…
   Biosense Webster, Inc. announced the completion of the first clinical cases with the new ® THERMOCOOL SF Irrigated Ablation catheter in the European Union, following recent CE Mark approval. The THERMOCOOL® SF catheter is the most advanced Biosens…
   Hansen Medical, Inc. announced that it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food & Drug Administration (FDA) authorizing a clinical trial to investigate use of the Sensei® X Robotic Catheter Sy…
   Medtronic, Inc. released new data from the MVP (Managed Ventricular Pacing) trial that implantable defibrillator patients receiving anti-tachycardia pacing (ATP) were less likely to have health care utilization after treatment as compared to those…
   nContact Surgical, Inc. (nContact) announced it has enrolled the first patient in its IDE trials to evaluate a fully closed chest procedure combining the best of electrophysiologist (EP) catheter and surgical techniques for the treatment of atrial…
   Stereotaxis, Inc. announced the introduction of its new VdriveTM, an expansion of its Magnetic Navigation platform that facilitates remote manipulation of diagnostic devices used during EP procedures. The Vdrive will be commercially available when…